Licensing and supply agreement for REZLIDHIA (olutasidenib)Licensing and Supply Agreement • November 9th, 2024
Contract Type FiledNovember 9th, 2024Rigel will receive product transfer price payments in the mid-twenty to lower-thirty percent range based on tiered net sales for the exclusive supply of REZLIDHIA